Oncotelic Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
Oncotelic Therapeutics, Inc. (OTLC) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 1.42 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-08-13
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-06-30 was 0.00 shares.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-03-31 was 1.42M shares.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-12-31 was 23.93M shares.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2024-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2025 was 29.27M shares, a 763.57% increase from fiscal 2024.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2024 was 3.39M shares, a 85.37% decline from fiscal 2023.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2023 was 23.16M shares, a 40.02% decline from fiscal 2022.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2022 was 38.62M shares, a 11.59% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 1.42M shares 10-Q · filed 2026-08-13 | 25.35M shares derived: sum of 3 quarters · filed 2026-08-13 | |
| 2026-03-31 | 1.42M shares 10-Q · filed 2026-05-14 | 25.35M shares derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2025-12-31 | 23.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 29.27M shares 10-K · filed 2026-04-15 | ||
| 2025-09-30 | 5.35M shares 10-Q · filed 2025-11-17 | |||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 0.00 shares derived: sum of 2 quarters · filed 2026-04-15 | 0.00 shares derived: sum of 3 quarters · filed 2026-04-15 | 3.39M shares 10-K · filed 2026-04-15 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-17 | 3.39M shares 10-Q · filed 2025-11-17 | 15.26M shares derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 3.39M shares 10-Q · filed 2025-08-13 | 15.26M shares derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | 3.39M shares 10-Q · filed 2025-05-15 | 15.26M shares derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | 11.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | 23.16M shares 10-K · filed 2025-04-15 | ||
| 2023-09-30 | 11.30M shares 10-Q · filed 2024-11-19 | |||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | 4.25M shares derived: sum of 2 quarters · filed 2024-04-12 | 5.62M shares derived: sum of 3 quarters · filed 2024-04-12 | 38.62M shares 10-K · filed 2024-04-12 |
| 2022-09-30 | 4.25M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 5.62M shares derived: sum of 2 quarters · filed 2023-11-14 | 38.62M shares 10-Q · filed 2023-11-14 | 49.20M shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | 1.38M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-18 | 34.38M shares 10-Q · filed 2023-08-18 | 44.95M shares derived: sum of 3 quarters · filed 2023-08-18 | 44.95M shares derived: sum of 4 quarters · filed 2023-08-18 |
| 2022-03-31 | 33.00M shares 10-Q · filed 2023-05-22 | 43.58M shares derived: sum of 2 quarters · filed 2023-05-22 | 43.58M shares derived: sum of 3 quarters · filed 2023-05-22 | 65.58M shares derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | 10.58M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-04-20 | 10.58M shares derived: sum of 2 quarters · filed 2023-04-20 | 32.58M shares derived: sum of 3 quarters · filed 2023-04-20 | 34.61M shares 10-K/A · filed 2023-04-20 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | 22.00M shares derived: sum of 2 quarters · filed 2021-11-22 | 24.04M shares 10-Q · filed 2021-11-22 | 24.59M shares derived: sum of 4 quarters · filed 2022-04-15 |
| 2021-06-30 | 22.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-20 | 24.04M shares 10-Q · filed 2021-08-20 | 24.59M shares derived: sum of 3 quarters · filed 2022-04-15 | 27.50M shares derived: sum of 4 quarters · filed 2022-04-15 |
| 2021-03-31 | 2.04M shares 10-Q · filed 2021-05-24 | 2.58M shares derived: sum of 2 quarters · filed 2022-04-15 | 5.50M shares derived: sum of 3 quarters · filed 2022-04-15 | 5.50M shares derived: sum of 4 quarters · filed 2022-04-15 |
| 2020-12-31 | 550.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | 3.46M shares derived: sum of 2 quarters · filed 2022-04-15 | 3.46M shares derived: sum of 3 quarters · filed 2022-04-15 | 17.21M shares 10-K · filed 2022-04-15 |
| 2020-09-30 | 2.92M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | 2.92M shares derived: sum of 2 quarters · filed 2020-11-16 | 16.66M shares 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | 13.75M shares 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | 13.75M shares 10-Q · filed 2020-06-29 | |||
| 2018-12-31 | 16.36M shares 10-K · filed 2020-05-14 |